1. Introduction {#sec0005}
===============

Na^+^--Ca^2+^ exchanger (NCX) proteins are widely distributed in different tissue types and play important roles in Na^+^ and Ca^2+^ ion homeostasis [@bib0005; @bib0010; @bib0015]. The stoichiometry of cardiac NCX1 exchange is generally held to be 3 Na^+^ ions for 1 Ca^2+^ ion such that the exchanger can function in both the 'forward' (Na^+^-entry, Ca^2+^-efflux) and 'reverse' (Na^+^-entry, Ca^2+^-efflux) modes, with the direction of transport determined by the intracellular and extracellular concentrations of the transported ions and transmembrane voltage gradient [@bib0005; @bib0020; @bib0025]. During ventricular action potentials (APs), initial membrane depolarisation may drive reverse-mode NCX activity, providing Ca^2+^ entry which can supplement that occurring via L-type calcium channels to facilitate calcium-induced calcium release from the sarcoplasmic reticulum (SR) [@bib0030; @bib0035; @bib0040]. Subsequent forward mode exchange acts to extrude Ca^2+^ across the sarcolemmal membrane; consequently, along with SR Ca^2+^ reuptake, NCX1 activity is a major mechanism for restoring low diastolic \[Ca^2+^\]~*i*~ levels [@bib0005; @bib0035]. Due to its stoichiometry, NCX activity is electrogenic and can influence AP profiles as well as cellular calcium handling [@bib0005; @bib0045]. Given these important roles, it is perhaps unsurprising that altered NCX activity can contribute to impaired excitation--contraction coupling and arrhythmogenesis in disease states [@bib0050]. The properties and regulation of NCX have been studied extensively by the voltage-clamp recording of NCX currents (*I*~NCX~) in isolated cardiac myocytes under selective conditions in which other major cation currents (e.g., Ca^2+^, K^+^, Na^+^, Na^+^/K^+^ ATPase) have been removed or inhibited [@bib0055; @bib0060; @bib0065; @bib0070; @bib0075]. Extracellular Ni^2+^ is used conventionally to measure *I*~NCX~ as it blocks both the inward and the outward *I*~NCX~ reliably and reversibly with no preference for either mode of transport [@bib0055; @bib0060; @bib0065].

Although it has been established that NCX1 can be phosphorylated by protein kinase A (PKA) and protein kinase C (PKC) at sites residing in the large intracellular loop of the NCX protein [@bib0080; @bib0085; @bib0090], *functional* regulation of mammalian NCX1 by the β-adrenoceptor/PKA pathway is controversial, with both reports of no alteration [@bib0095; @bib0100; @bib0105; @bib0110; @bib0115; @bib0120] or upregulation [@bib0010; @bib0070; @bib0075; @bib0125; @bib0130; @bib0135] of NCX activity in different studies. For example, previous work from this laboratory has provided evidence for an increase in guinea-pig ventricular NCX activity at 37 °C through the β-adrenoceptor/PKA pathway [@bib0070; @bib0075; @bib0125]: the currents recorded during voltage-ramps in NCX recording conditions were stimulated by the β-adrenoceptor agonist, isoprenaline (ISO), by the adenylyl cyclase activator, forskolin, or by raised \[cAMP\]~*i*~ and the rate of decay of caffeine-induced \[Ca^2+^\]~*i*~ transients were accelerated by high \[cAMP\]~*i*~ [@bib0075]. There are also reports of stimulation of NCX1 activity measured as ^45^Ca^2+^ uptake for both recombinant NCX1 and native rat ventricular NCX [@bib0140; @bib0145] and of *I*~NCX~ for swine ventricular myocytes [@bib0150; @bib0155]. On the other hand, it has been suggested that β-adrenoceptor activated changes in ionic current under *I*~NCX~-'selective' conditions could result instead from activation of the CFTR (cystic fibrosis transmembrane conductance regulator)-mediated *I*~Cl,PKA~, as this current in guinea-pig myocytes has been reported to be sensitive to extracellular Ni^2+^-application when it is activated by isoprenaline, though not when activated by forskolin [@bib0120]. Furthermore, in a study of rabbit ventricular myocytes, Ginsburg and Bers reported no alteration to NCX activity estimated from caffeine-induced Ca^2+^-transient decay or of caffeine induced \[Ca^2+^\]~*i*~ and inward *I*~NCX~ under perforated-patch conditions used to assess rate of Ca^2+^ extrusion via NCX [@bib0115]. Also, in the same study [@bib0115] rabbit ventricular *I*~NCX~ elicited by a voltage-ramp protocol was not enhanced by a brief period of isoprenaline application, the authors concluded that under those conditions rabbit ventricular *I*~NCX~ was not modulated by isoprenaline [@bib0115]. Differences between experimental preparations/species, protocols and conditions may contribute to the differing conclusions regarding PKA-modulation of NCX in the literature [@bib0025]. Consequently, the present study was undertaken to determine whether or not *I*~NCX~ from rabbit ventricular myocytes can be augmented by the β-adrenoceptor/PKA pathway during sustained application of voltage-ramp protocols using conditions that have been extensively used in prior studies of *I*~NCX~ at mammalian body temperature [@bib0060; @bib0065; @bib0070; @bib0075]. To investigate the contribution of *I*~Cl,PKA~ to the activated currents, recordings were also made from rabbit ventricular myocytes under Cl^−^-selective conditions [@bib0160] and from rabbit atrial myocytes, which lack PKA-dependent Cl^−^ current [@bib0165], under *I*~NCX~ recording conditions.

2. Materials and methods {#sec0010}
========================

2.1. Cell isolation {#sec0015}
-------------------

Right ventricular and left atrial myocytes were isolated from Langendorff-perfused rabbit hearts by enzymatic and mechanical dispersion, as described previously [@bib0170]. All procedures were approved by the Ethics Committee of the University of Bristol and were performed according to the UK Animals (Scientific Procedures) Act, 1986. Male New Zealand White rabbits (2.0--3.0 kg) were killed by cervical dislocation and the heart removed promptly via median thoracotomy. The excised heart was placed in a cold (4 °C) heparinised Tyrode\'s isolation solution ([Table 1](#tbl0005){ref-type="table"}) to which 750 μM Ca had been added and the aorta was then cannulated quickly into a Langendorff perfusion system. The heart was perfused retrogradely at 37 °C first with isolation solution containing 750 μM Ca^2+^ for 2 min, followed by 4 min perfusion with the isolation solution containing 100 μM EGTA. Perfusate was then switched to an isolation solution containing a low concentration of Ca^2+^ (240 μM) supplemented with collagenase (Worthington type 1, 1 mg/ml) and protease (Sigma type XIV, 0.1 mg/ml) for 6 min. The heart was then cut off from the cannula and the right ventricular and left atrial free wall were excised into two separate sterile Petri dishes. Using a pair of fine scissors, these excised tissues were chopped into smaller pieces. The chopped tissue was then shaken in a water-bath with re-circulation enzyme and 2% bovine serum albumin (BSA) at 37 °C for 5--10 min. It was then filtered through nylon gauze (200 μm diameter mesh) into a solution containing 3% BSA and 1.5 ml of Kraft-Brühe (KB) medium [@bib0175]. The filtrate was centrifuged for 40 s and the supernatant was discarded. The pellet was re-suspended in fresh KB medium and stored at 4 °C. Cells were used within 8 h after isolation and only cells with clear rod shape and striations were used for recordings.

2.2. Electrophysiological recording and data acquisition {#sec0020}
--------------------------------------------------------

Whole cell patch clamp experiments were performed at 37 °C. The compositions of all experimental solutions used in the patch-clamp recordings are shown in [Table 1](#tbl0005){ref-type="table"}. An aliquot of cell suspension was placed onto a glass chamber (∼1 ml volume) on the stage of an inverted microscope (Olympus CK40) and the cells were superfused with standard external Tyrode\'s solution. Experiments were carried out with an Axopatch 200B amplifier (Axon Instruments, USA). Protocols were generated and recorded with PulseFit software (HEKA Elektronik GmbH, Germany) via an analogue-to-digital converter (ITC-16 computer interface, Instrutech Corporations, USA). Patch-pipettes (Corning 7052 glass, AM Systems Inc., USA) were pulled on a horizontal micropipette puller (Model P-97, Sutter Instruments Company) to a resistance of 2.0--3.5 MΩ. Series resistance and membrane capacitance were compensated prior to acquiring any recordings. Data were recorded at 1 kHz. External solutions were applied using a temperature-controlled rapid solution application device [@bib0180].

For *I*~NCX~ recordings, once the whole-cell configuration was achieved, the external superfusate was changed to an NCX-recording solution as used in previous studies (e.g., [@bib0065; @bib0185]). This K^+^-free solution (to abolish inward rectifier K^+^-current), contained 10 μM each of nitrendipine (to inhibit the L-type Ca^2+^ currents) and strophanthidin to block the Na^+^--K^+^-pump ([Table 1](#tbl0005){ref-type="table"}). *I*~NCX~ was measured as the current sensitive to rapid application of 10 mM Ni^2+^. This concentration of Ni^2+^ has previously been shown to be maximally effective in blocking *I*~NCX~ [@bib0065]. A voltage ramp protocol was applied from a holding potential of −80 mV once every 10 s; voltage was stepped to +80 mV for 100 ms before a downward ramp to −120 mV over 2 s [@bib0060]. For Ni^2+^-sensitive difference currents, current in the presence of Ni^2+^ was subtracted from current in control, ISO, noradrenaline (NA) or forskolin, as appropriate.

Recordings of *I*~Cl,PKA~ were made as described previously [@bib0160]. The K^+^- and Ca^2+^-free external and internal solutions used are shown in [Table 1](#tbl0005){ref-type="table"}. For experiments using low external \[Cl^−^\] (21 mM), Cl^−^ was replaced with aspartate. In order to avoid any change in the liquid junction potential with the low external Cl^−^ solutions, an agar bridge with 3 M KCl was used. To record *I*~Cl,PKA~, a sawtooth voltage ramp was applied from a holding potential of 0 mV incorporating a downward ramp from +100 mV to −100 mV over 1 s [@bib0160]. Recordings of *I*~Ca,L~ were made using the internal solution as used for *I*~Cl,PKA~ recording and a K^+^-free Tyrode\'s external solution in which K^+^ was replaced with equimolar Cs^+^.

2.3. Chemicals {#sec0025}
--------------

Chemicals used in the cell-isolation were obtained from British Drug House (BDH, Aristar-grade) or Sigma--Aldrich. Strophanthidin and nitrendipine were dissolved in ethanol as 10 mM stock and appropriate dilutions were added to the external solutions used in the experiments to get a final concentration of 10 μM each. Each of 1 μM isoprenaline (ISO), 1 μM noradrenaline (NA) and 10 μM forskolin (Sigma--Aldrich) were used to activate β-adrenoceptor/PKA in separate experiments; previous studies have used similar concentrations of these compounds to activate maximally the exchanger and the Cl^−^ channel currents [@bib0100; @bib0120; @bib0125]. Stock solutions were made fresh in de-ionised water (ISO and NA) or ethanol (forskolin) on the day of experiment and appropriate dilutions were added to the external solutions as needed.

2.4. Data analysis and presentation {#sec0030}
-----------------------------------

Data were analyzed using Igor Pro (WaveMetrics, Inc., USA), Excel 2003 and GraphPad Prism software. Data are presented as mean ± standard error of the mean (SEM), '*n*' values refer to the number of cells for particular observations (typically from at least two hearts). Membrane current and membrane potential are referred to as *I*~m~ and *V*~m~, respectively, in subsequent text and figures. Statistical comparisons were made using a paired Student\'s *t* test or one or two-way ANOVA as appropriate. *P* values of less than 0.05 were considered to be statistically significant.

3. Results {#sec0035}
==========

3.1. Isoprenaline activates a current under NCX-recording conditions that is Ni^2+^-sensitive {#sec0040}
---------------------------------------------------------------------------------------------

As shown in [Fig. 1](#fig0005){ref-type="fig"}A, superfusion of the cells with solution containing 1 μM ISO increased the control current several fold (e.g., at +80 mV, ISO activated the control current 4.0 ± 1.2 fold; *n* = 7). As reported previously, using similar recording conditions in guinea pig ventricular myocytes [@bib0075], the ISO-activated current was completely inhibited by further application of 10 mM Ni^2+^ in the presence of 1 μM ISO. [Fig. 1](#fig0005){ref-type="fig"}B shows the mean *I*--*V* relationships of the net whole-cell currents; the control currents were significantly increased by 1 μM ISO at extremes of voltages tested in the ramp protocol and 10 mM Ni^2+^ in the presence of same concentration of ISO abolished the ISO-activated current.

3.2. *I*~Cl,PKA~ activated via β-adrenoceptor stimulation is Ni^2+^-sensitive {#sec0045}
-----------------------------------------------------------------------------

To determine the Ni^2+^ sensitivity of the β-adrenoceptor-activated *I*~Cl,PKA~, we used Cl^−^-recording conditions and each of 1 μM ISO or 1 μM NA as the β-agonists. [Fig. 2](#fig0010){ref-type="fig"}A (upper panel) shows the representative net whole-cell currents; as was found under NCX recording conditions, the 1 μM ISO-activated *I*~Cl,PKA~ was completely inhibited by 10 mM Ni^2+^. [Fig. 2](#fig0010){ref-type="fig"}B (i) shows the *I*--*V* relationships of the ISO-activated difference current and the Ni^2+^-sensitive current in the presence of ISO, demonstrating that the two currents were equivalent to each other; the mean data from 4 cells are shown in [Fig. 2](#fig0010){ref-type="fig"}B (ii). Similarly, the *I*~Cl,PKA~ activated by the physiological β-adrenoceptor agonist NA was also completely inhibited by Ni^2+^, as shown in [Fig. 2](#fig0010){ref-type="fig"}C (i) and (ii).

3.3. Forskolin-activated *I*~Cl,PKA~ is not Ni^2+^-sensitive {#sec0050}
------------------------------------------------------------

In contrast to the currents activated by the β-agonists, when activated downstream to the β-adrenoceptors using 10 μM forskolin, *I*~Cl,PKA~ was insensitive to 10 mM Ni^2+^. [Fig. 3](#fig0015){ref-type="fig"}A shows the time-course of an experiment done under Cl^−^ recording conditions, presenting the net whole-cell currents measured at −100 mV and +100 mV; the forskolin activated current was insensitive to Ni^2+^. On the other hand, lowering the external solution Cl^−^ concentration (to 21 mM) attenuated the current and shifted the reversal potential to a more positive value (trace iv, [Fig. 3](#fig0015){ref-type="fig"}B), confirming the forskolin-activated current to be Cl^−^-selective. [Fig. 3](#fig0015){ref-type="fig"}C shows the mean *I*--*V* relationships of the Ni^2+^-sensitive difference currents in control and the Ni^2+^-sensitive difference currents in the presence of forskolin. In summary, there was no Ni^2+^-sensitive element to the forskolin-activated *I*~Cl,PKA~.

3.4. Forskolin does not upregulate Ni^2+^-sensitive *I*~NCX~ in either rabbit ventricular or atrial myocytes {#sec0055}
------------------------------------------------------------------------------------------------------------

Having established that *I*~Cl,PKA~ activated by forskolin was insensitive to Ni^2+^, we investigated the effect of 10 mM Ni^2+^ on the current activated by the same concentration of forskolin (10 μM) under NCX recording conditions. [Fig. 4](#fig0020){ref-type="fig"}A shows the time-course of a typical experiment on a rabbit ventricular myocyte with net whole-cell currents sampled at −120 mV and +80 mV. Following the initial run-up in the current, Ni^2+^ was applied to obtain a measure of *I*~NCX~ under control conditions. After washout of the Ni^2+^, application of forskolin resulted in a further increase in the current. There was indeed a Ni^2+^-sensitive component to the current in the presence of forskolin under the NCX recording conditions. However, the *I*--*V* relationships of the Ni^2+^-sensitive difference currents in control and the Ni^2+^-sensitive currents in the presence of forskolin as shown in [Fig. 4](#fig0020){ref-type="fig"}B (traces ii and iii) were effectively identical. The *I*--*V* relationships of the mean data are shown in [Fig. 4](#fig0020){ref-type="fig"}C. Thus, forskolin did not increase *I*~NCX~ under these recording conditions.

Since rabbit atrial myocytes have been shown to lack *I*~Cl,PKA~ [@bib0165], similar experiments were carried out using atrial cells as shown in [Fig. 5](#fig0025){ref-type="fig"}. 10 μM forskolin did not activate the basal net whole-cell current and the Ni^2+^-sensitive difference currents in control solution were identical to the Ni^2+^-sensitive currents in the presence of forskolin (*I*--*V* relationships of the representative difference currents and mean data are shown in [Fig. 5](#fig0025){ref-type="fig"}B and C). In order to verify whether the concentration of forskolin being used was effective in activating PKA-dependent pathways, we tested the effect of 10 μM forskolin on the L-type Ca^2+^ current (*I*~Ca,L~) in rabbit atrial cells isolated from the same hearts; forskolin increased *I*~Ca,L~ by 2.57 ± 0.71 fold (*n* = 8, data not shown).

4. Discussion {#sec0060}
=============

We have investigated the effects of acute β-adrenoceptor/PKA-stimulation on currents in rabbit ventricular and atrial myocytes under conditions previously considered 'selective' for NCX; we also tested the sensitivity of the PKA-activated Cl^−^ current, *I*~Cl,PKA~, to Ni^2+^. Our results provide novel evidence that the apparent increase in *I*~NCX~ with β-adrenoceptor stimulation in rabbit cardiac myocytes is likely due to activation of a PKA-activated Cl^−^ current, which is also sensitive to Ni^2+^ when activated proximal to the β-adrenoceptors. Importantly, data from rabbit atrial myocytes, which do not express PKA-dependent CFTR Cl^−^ channels, demonstrate that *I*~NCX~ was not increased in the absence of *I*~Cl,PKA~; to the best of our knowledge, this represents the first investigation of the effects of PKA-stimulation on *I*~NCX~ in rabbit atrial myocytes. In addition, Ni^2+^ acts to inhibit the response to β-adrenoceptor stimulation at the level of the receptor, but not downstream.

Consistent with previous studies [@bib0120], β-adrenoceptor stimulation, using either isoprenaline or noradrenaline, elicited an increase in current in the NCX-recording conditions. However this apparent increase in current is suggested to reflect activation of *I*~Cl,PKA~ as both the *I*~NCX~ and *I*~Cl,PKA~ were found to be sensitive to Ni^2+^ when activated by β-adrenoceptor stimulation: similar to the report by Lin et al. in guinea pig myocytes [@bib0120], *I*~Cl,PKA~ in rabbit ventricular myocytes was sensitive to extracellular Ni^2+^ when activated by β-adrenoceptor agonists, but not when activated downstream to the receptor by forskolin. This suggests that Ni^2+^ inhibits *I*~Cl,PKA~ upstream to adenylyl cyclase, most likely at the level of β-adrenoceptors. Thus, since the NCX recording conditions in this study did not preclude the contribution of Cl^−^ currents [@bib0025; @bib0030], *I*~Cl,PKA~ is very likely to have contributed to the Ni^2+^-sensitive currents activated by β-adrenoceptor stimulation under NCX recording conditions. On the other hand, the effects on *I*~NCX~ of PKA stimulation via forskolin can be measured reliably as the change in Ni^2+^-sensitive current. Since *I*~Cl,PKA~ is absent from rabbit atrial myocytes [@bib0165], it was possible to examine the modulation of the Ni^2+^-sensitive *I*~NCX~ in these cells with minimal contamination by *I*~Cl,PKA~. Consistent with this, the basal net whole-cell current was not increased by 10 μM forskolin in rabbit atrial cells ([Fig. 5](#fig0025){ref-type="fig"}A). Importantly the Ni^2+^-sensitive *I*~NCX~ was not stimulated by forskolin ([Fig. 5](#fig0025){ref-type="fig"}C). Thus, under NCX recording conditions, the Ni^2+^-sensitive difference current in control and the Ni^2+^-sensitive current in the presence of forskolin were superimposable, both in rabbit ventricular ([Fig. 4](#fig0020){ref-type="fig"}B) and atrial myocytes ([Fig. 5](#fig0025){ref-type="fig"}B). This demonstrates that activation of the PKA-pathway via forskolin does not increase *I*~NCX~ under these conditions.

Whilst our finding of an effect of extracellular Ni^2+^ at the level of β-adrenoceptors is consistent with that reported by Lin et al. in guinea pig ventricular myocytes [@bib0120], our results in part contrast with those of Ginsberg and Bers [@bib0115]: whilst both studies report a lack of activation of rabbit *I*~NCX~ via the PKA-pathway, Ginsburg and Bers reported the isoprenaline-activated *I*~Cl,PKA~ in rabbit ventricular myocytes to be insensitive to Ni^2+^ [@bib0115], whereas we found it to be Ni^2+^-sensitive. The reasons for this apparent discrepancy are unclear. Whilst the precise mechanism for the action of extracellular Ni^2+^ in our study and that of Lin et al. [@bib0120] remains unknown, taken together, the data are compatible with a previously established role for extracellular divalent cations in ligand binding to G-protein-coupled receptors [@bib0190].

Although it is clear from our data that, under the conditions of the present study, stimulation of the PKA-pathway downstream to the receptors does not activate rabbit *I*~NCX~, we cannot exclude entirely the possibility that activation of β-adrenoceptors may modulate NCX function in this species. As there is evidence of compartmentalization of cAMP signalling in sub-cellular microdomains, activation of PKA via β-adrenoceptor stimulation may elicit distinct effects to activation of PKA via forskolin [@bib0195]. Evidence for a role of the subcellular environment in the NCX response to PKA-phosphorylation is provided by the observation that while NCX1 activity was shown to be upregulated by PKA in rat myocytes and *Xenopus* oocytes [@bib0135], there was no alteration in the NCX1 activity in response to PKA stimulation when NCX1 was heterologously expressed in HEK293 cells [@bib0140]. It has been suggested that NCX1 may be part of a 'macromolecular complex' along side PKA-subunits, protein kinase C, protein kinase-A anchoring proteins (mAKAP) and protein phosphatases PP1 and PP2A [@bib0025; @bib0145]. It is also possible that the basal levels of phosphorylation of various PKA-targets including the NCX vary, which will influence the sensitivity to β-adrenoceptor-mediated changes in the *I*~NCX~; this was indeed shown in failing pig myocytes where there was a higher basal level of phosphorylation of NCX by PKA, which lead to a greater basal *I*~NCX~ [@bib0150]. That study also demonstrated almost 500% increase in *I*~NCX~ in non-failing pig myocytes with β-adrenoceptor stimulation [@bib0150].

5. Conclusions {#sec0065}
==============

We conclude that, under experimental conditions in which major voltage and time-dependent conductances are inhibited: (i) there is contamination by *I*~Cl,PKA~ in the apparent activation of rabbit ventricular *I*~NCX~ seen with β-adrenoceptor stimulation and (ii) that the Ni^2+^-sensitive *I*~NCX~ is not upregulated by PKA-stimulation in conditions where *I*~Cl,PKA~ is absent. Our results in respect of effects of Ni^2+^ are consistent with those of Lin et al. [@bib0120]. The conclusions of our study are concordant with those of Ginsberg and Bers [@bib0115] in that we did not see any upregulation of Ni^2+^-sensitive *I*~NCX~ with PKA-stimulation in rabbit myocytes under the conditions used at 37 °C. This does not exclude the possibility of modulation of *I*~NCX~ via this pathway under other conditions or in other species. The findings of this study further warn us to be aware of contaminating membrane currents under conditions otherwise thought to be 'selective', especially in ventricular cells when *I*~NCX~ is measured as the Ni^2+^-sensitive current.
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![Effect of 1 μM ISO and 10 mM Ni^2+^ on whole-cell currents under NCX-recording conditions. (A) Representative traces of the net whole-cell currents in control solution, following superfusion with ISO-containing solution and in the presence of both ISO and Ni^2+^ (upper panel); voltage ramp protocol is shown in the lower panel. (B) Mean current density--voltage (*I*--*V*) relationships of the net whole-cell currents (*n* = 7). \**P* \< 0.05, \*\**P* \< 0.01, \*\*\**P* \< 0.001 (Bonferroni\'s post hoc test).](gr1){#fig0005}

![Effect of β-adrenoceptor agonists and Ni^2+^ on I~Cl,PKA~. (A) Representative traces of net whole-cell current in control and the current activated by 1 μM ISO and the current in the presence of same concentration of ISO + Ni^2+^ (10 mM). Lower panel shows the voltage ramp protocol. (B) *I*--*V* relationships of the current activated by ISO and the current blocked by Ni^2+^ in the presence of ISO: (i) representative traces (ii) mean (*n* = 4) of ISO-activated currents (open squares) and Ni^2+^-sensitive currents (filled squares). (C) *I*--*V* relationship of the current activated by NA and the current blocked by Ni^2+^ in the presence of NA: (i) representative traces (ii) mean (*n* = 5) of NA-activated currents (open triangles) and Ni^2+^-sensitive currents (filled triangles).](gr2){#fig0010}

![Effect of 10 μM forskolin and 10 mM Ni^2+^ on *I*~Cl,PKA~. (A) Representative time-course of changes in currents with superfusion of forskolin and Ni^2+^ sampled at +100 mV (open circles) and −100 mV (filled circles). (B) *I*--*V* relationships of the net whole-cell currents as shown in A. (C) Mean (*n* = 6) *I*--*V* relationships of the currents activated by forskolin (open triangles) and the currents blocked by Ni^2+^ in the presence of forskolin (filled triangles) \**P* \< 0.05, \*\**P* \< 0.01, \*\*\**P* \< 0.001 (Bonferroni\'s post hoc test).](gr3){#fig0015}

![Effect of 10 μM forskolin and 10 mM Ni^2+^ on whole-cell currents under NCX-recording conditions in rabbit ventricular cells. (A) Representative time-course of changes in currents with superfusion of forskolin and Ni^2+^ sampled at +80 mV (open circles) and −120 mV (filled circles). (B) *I*--*V* relationships of the currents blocked by Ni^2+^ in control (i and ii) and in the presence of forskolin (iii and iv). (C) Mean (*n* = 5) *I*--*V* relationships of the Ni^2+^-sensitive current in control (filled diamonds) and Ni^2+^-sensitive current with forskolin (filled squares).](gr4){#fig0020}

![Effect of forskolin and Ni^2+^ in whole-cell currents under NCX-recording conditions in rabbit atrial cells. (A) Representative time-course of changes in currents with superfusion of forskolin and Ni^2+^ sampled at +80 mV (open circles) and −120 mV (filled circles). (B) *I*--*V* relationships of the currents blocked by Ni^2+^ in control (i and ii) and in the presence of forskolin (ii and iii). (C) Mean (*n* = 4) *I*--*V* relationships of the Ni^2+^-sensitive difference current in control (filled upward triangles) and Ni^2+^-sensitive current with forskolin (filled downward triangles).](gr5){#fig0025}

###### 

Compositions of solutions (mM).

  Constituents                    Isolation solution   External solutions   Internal solutions                     
  ------------------------------- -------------------- -------------------- -------------------- ----- ----- ----- -----
  NaCl                            130                  140                  140                  150   18    10    --
  KCl                             4.5                  4                    --                   --    --    --    --
  HEPES                           5                    5                    5                    10    10    10    10
  MgCl~2~                         3.5                  1                    1                    0.5   0.5   0.4   0.5
  Glucose                         10                   10                   10                   11    11    5     5.5
  NaH~2~PO~4~                     0.4                  --                   --                   --    --    --    --
  TEACl                           --                   --                   --                   --    --    20    20
  EGTA                            --                   --                   --                   --    --    5     10
  CaCl~2~                         --                   2.5                  2.5                  --    --    1     --
  CsCl                            --                   --                   --                   --    --    110   --
  BaCl~2~                         --                   --                   1                    --    --    --    --
  [l]{.smallcaps}-Aspartic acid   --                   --                   --                   --    132   --    85
  MgATP                           --                   --                   --                   --    --    --    10
  Na--creatine PO~4~              --                   --                   --                   --    --    --    5
  Na--GTP                         --                   --                   --                   --    --    --    0.1
  CdCl~2~                         --                   --                   --                   1     1     --    --
  Nitrendipine                    --                   --                   0.01                 --    --    --    --
  Strophanthidin                  --                   --                   0.01                 --    --    --    --

pH of the external solutions 7.45 at room temperature with NaOH and for the internal solution 7.2 with CsOH. NT: normal Tyrode\'s solution.
